History and mission

TEDD ( Tissue Engineering for Drug Developemnt and Substance Testing) was established together with the introduction of 3D cell cultures technologies to the wider audience. The center aims at fostering 3D cell culture approaches for drug development, personalized, regenerative medicine and basic science, contributing actively to key technology development and translating in vitro assays into predictive tests of clinical and pharmaceutical relevance. In order to maximize the success, cooperation of partners with complementary skills – academia, industry (in particular biotechnology, pharmaceutical, medtech and cosmetics companies) and clinics is required. TEDD community strengthen the research and business location of Switzerland and Europe by responding to key medical, pharmaceutical and societal demands. By routine application of 3D tissue models, the 3Rs initiative will be implemented by reducing, refining and replacing animal experimentation.

 

More details…

Website Link…

 

Recent Posts

Skinobs revamps We Are Testing® with a bold new identity

Skinobs Revamps “We Are Testing” with a bold new identity and website ahead of NYSCC…

We Are Testing® at NYSCC Suppliers’ Day 2025

👉 The Skinobs team will be delighted to welcome you booth 857, to talk with…

Pollution, a relevant exposome factor in skin aging and the role of multi-benefit photoprotection via ACTAS

J. Santamaria, Y. Gilaberte, L. Prudkin, J. Piquero-Casals 11 March 2025 Skin aging is a…